Ado-trastuzumab emtansine Intravenous and NovoLog PenFill
Determining the interaction of Ado-trastuzumab emtansine Intravenous and NovoLog PenFill and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Novoseven
- Ado-trastuzumab emtansine Intravenous-NovoSeven RT
- Ado-trastuzumab emtansine Intravenous-NovoSeven RT with MixPro injection
- Ado-trastuzumab emtansine Intravenous-Novothyrox
- Ado-trastuzumab emtansine Intravenous-Noxafil
- Ado-trastuzumab emtansine Intravenous-Noxafil (Posaconazole Delayed-Release Tablets)
- NovoLog PenFill-Adox Pak 2/100
- NovoLog PenFill-Adoxa
- NovoLog PenFill-Adoxa CK
- NovoLog PenFill-Adoxa Pak
- NovoLog PenFill-Adoxa Pak 1/100
- NovoLog PenFill-Adoxa Pak 1/150